3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 1 studies
| Studies (3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide) | Trials (3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide) | Recent Studies (post-2010) (3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide) | Studies (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Trials (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) | Recent Studies (post-2010) (1-(5-isoquinolinesulfonyl)-2-methylpiperazine) |
|---|---|---|---|---|---|
| 27 | 0 | 4 | 3,412 | 41 | 631 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsusaka, S; Wakabayashi, I | 1 |
1 other study(ies) available for 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
5-Hydroxytryptamine as a potent migration enhancer of human aortic endothelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Aorta; Benzamides; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Cell Movement; Cells, Cultured; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Fluoxetine; Humans; Microscopy, Video; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; Pyridines; rhoA GTP-Binding Protein; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists; Stress Fibers; Time Factors | 2005 |